www.peacefulmeds.com
Has www.peacefulmeds.com received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued www.peacefulmeds.com a warning letter naming semaglutide, dated May 5, 2025, with the FDA subject line “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet.”
FDA records in this index name www.peacefulmeds.com on May 5, 2025.
- Websites the letters name
- peacefulmeds.com (see how each letter refers to them)
- Type named in FDA records
- Online seller
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide
- Latest record
- May 5, 2025
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| May 5, 2025 | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet | Semaglutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- May 5, 2025: … introduces into interstate commerce misbranded injectable semaglutide drug products. Injectable drug products can pose … FDA has observed that www.peacefulmeds.com offers semaglutide drug products without requiring a prescription: Your description of semaglutide marketed as “2 Pens Ozempic 1mg,” “Ozempic 0.25 … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- peacefulmeds.com: FDA’s warning letter of May 5, 2025 is addressed to www.peacefulmeds.com. It refers to the site in these words: “… is to advise you that the United States (U.S.) Food and Drug Administration (FDA) recently reviewed your website at the Internet address www.peacefulmeds.com and has observed that your website introduces into interstate commerce misbranded and unapproved new drugs in violation of sections 301(a), …” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.